COMMUNIQUÉS West-GlobeNewswire

Imprivata Research Finds that Only 32% of Public Safety Agencies are Fully Compliant with Criminal Justice Information Services Requirements
30/06/2026
Nearly all public safety professionals report access and security friction when accessing critical systems, highlighting challenges to achieving CJIS compliance WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- [...]
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30/06/2026
LITTLETON, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment of breathing‑ [...]
TPN.health Introduces Proprietary Integrated Claims and Credentialing Platform: Resolves Patient Barriers to Behavioral Health Access and Ensures Clinician Payments
30/06/2026
NEW ORLEANS, June 30, 2026 (GLOBE NEWSWIRE) -- TPN.health , the operating system for behavioral health, highlights the value of the first-of-its-kind integrated claims and credentialing platform that connects provider [...]
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
30/06/2026
- Milestone an important step in launching Trinovium within the global AI data center ecosystem - Data center liquid cooling market projected to expand from $4 billion in 2026 to $27 billion by 2033 1 DUBLIN and [...]
Sharecare teams up with AWS to deliver health navigation through agentic, multi-model AI with AskMD
30/06/2026
AskMD orchestrates multiple foundation models through a single governed layer to deliver secure, scalable, insurance-aware health guidance tailored to the individual ATLANTA, June 30, 2026 (GLOBE NEWSWIRE) -- Sharecare [...]
Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026
30/06/2026
Multi-omics analyses identifies linoleic acid as a critical fatty acid which is modulated by ART26.12 SOLANA BEACH, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage [...]
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026
Company celebrated for advancing global access to its innovative robotic surgery platform FORT LAUDERDALE, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS [...]
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
30/06/2026
Virtual health platform offers an additional pathway to care for the more than 45 million people in the U.S. living with eczema, seborrheic dermatitis, and plaque psoriasis Connects eligible individuals with independent [...]
Biosphere Expands Biomanufacturing Platform with NovoNutrients Acquisition
30/06/2026
Acquisition strengthens Biosphere’s advanced bioreactor platform and accelerates development of bioproducts across defense, industrial and commercial markets OAKLAND, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Biosphere [...]
Adam Ferrari Health Science Scholarship Closes 2026 Application Window
30/06/2026
The Ferrari Foundation Begins Finalist Review for Its $20,000 Award, with a Recipient to Be Named September 1, 2026 IRVINE, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- The Ferrari Foundation has closed the 2026 [...]
FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience
30/06/2026
Strategic collaboration at Sanford, North Carolina facility, currently under construction, to optimize cGMP validation, accelerate time-to-market for complex biologics, and shore up U.S. medicine supply TOKYO and [...]
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
30/06/2026
ISCC certification reflects Nelipak’s commitment to supporting customers with innovative and sustainable packaging solutions CRANSTON, R.I., June 30, 2026 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading [...]
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
30/06/2026
SCOTTSDALE, Ariz., June 30, 2026 (GLOBE NEWSWIRE) -- Applied Biologics today announced the expansion of its national commercial organization as the Company continues to support growing demand for XWRAP® while preparing [...]
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants
30/06/2026
June 30, 2026 Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “ [...]
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
30/06/2026
Key U.S. patent now protects exclusivity for developing stenoparib with the stenoparib-DRP ® until April 2042 TARPON SPRINGS, Fla., June 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR [...]
MediciNova CEO Provides Shareholder Update
30/06/2026
LA JOLLA, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1
30/06/2026
GeneTAC ® small molecule designed to selectively reduce transcription of the mutant DMPK allele and address the underlying cause of DM1 CARLSBAD, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. ( [...]
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
30/06/2026
Dose-optimization data from the Phase 1 study expected Q3 2026 to support Phase 2 proof-of-concept initiation in ADPKD in Q4 2026 JERSEY CITY, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX ), a [...]
Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease
30/06/2026
WILMETTE, Ill., June 30, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]

Pages